The latest healthcare stories from the Impact desk.
Bengaluru: Dr. Devi Shetty has emerged as one of the most influential figures in India’s healthcare sector, redefining accessibility by building one of the world’s most affordable and scalable cardiac care models through Narayana Health.
New Delhi: In India’s vast rural landscape, where access to quality healthcare has long been a challenge, artificial intelligence (AI) is emerging as a powerful tool to bridge the gap between patients and medical expertise. With limited availability of doctors, inadequate infrastructure, and long travel distances, millions of people in remote areas have historically struggled to receive timely diagnosis and treatment. Today, technology is beginning to change that narrative.
Manipal Health Enterprises has signed a Business Transfer Agreement to acquire Kinder Women's Hospital in Bengaluru, expanding its footprint in maternal and women's healthcare.
Omnichannel diagnostics provider Redcliffe Labs has acquired Pune-based Megavision Diagnostics Centre for approximately Rs 40 crore, bringing MRI, CT and other imaging services into its network as part of a broader push toward integrated, more accessible diagnostic care across western India.
Karnataka's food safety authorities have suspended the food licences of Amazon, Swiggy Instamart and BigBasket, citing compliance lapses that raise fresh questions about regulatory oversight in India's fast-scaling quick-commerce sector.
Bournvita maker Mondelez India, Amway and several other packaged food companies have dropped or modified health and nutrition claims on their products following action by India's food safety regulator, FSSAI.
xStep, founded by neuroscientist Dr Parag Gad, has raised fresh capital from Titan Capital to scale a spinal neuromodulation platform treating cerebral palsy, stroke, spinal cord injury and multiple sclerosis.
Biotech company ProFound Therapeutics has raised $35 million from the Bill & Melinda Gates Foundation to advance its AI platform for discovering novel protein-based drug targets.
Child healthtech venture Sunshine by LISSUN has raised ₹48 crore to expand its network of physical development centres and AI-enabled tools for children with special needs across Indian cities.